Maarten van Den Buuse
Research Subjects
Research Interests
Maarten van Den Buuse has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Sally Martin
Behavioural Neuroscience Laboratory, Mental Health Research Institute of Victoria, 155 Oak Street, Parkville, Victoria 3052, Australia
6 shared publications- Snezana Kusljic
Department of Nursing, The University of Melbourne, Melbourne, Victoria, Australia
5 shared publications - Andrea Gogos
The Florey Insitute of Neuroscience and Mental Health
4 shared publications - Margaret E. E. Jones
Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia
3 shared publications - Carolina A. Chavez
The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC 3052, Australia
2 shared publications - Jan Brosda
Institute of Pharmacology and Toxicology, School of Veterinary Medicine, Freie Universität Berlin, 14195, Berlin, Germany.
2 shared publications
Latest Publications
- 22 August 2008
- Published by Elsevier in Behavioural Brain Research
- Vol. 191 (2) , 289-293
Phencyclidine-induced locomotor hyperactivity is enhanced in mice after stereotaxic brain serotonin depletion
- 22 August 2008
- Published by Elsevier in Behavioural Brain Research
- Vol. 191 (2) , 289-293
Phencyclidine-induced locomotor hyperactivity is enhanced in mice after stereotaxic brain serotonin depletion
- 8 April 2008
- Published by Wiley in Hippocampus
- Vol. 18 (7) , 655-667
Combined neonatal stress and young‐adult glucocorticoid stimulation in rats reduce BDNF expression in hippocampus: Effects on learning and memory
Epidemiological studies suggest that multiple developmental disruptions are involved in the etiology of psychiatric illnesses including schizophrenia. In addition, altered expression of brain‐derived neurotrophic factor (BDNF) has been implicated in these illnesses. In the present study, we examined the combined long‐term effect of an early stress, in the form of maternal deprivation, and a later stress, simulated by chronic young‐adult treatment with the stress hormone, corticosterone, on BDNF expression in the hippocampus of rats. To assess whether there were behavioral effects, which may correlate with the BDNF changes, learning and memory was tested in the Y‐maze test for short term spatial memory, the Morris water maze for long‐term spatial memory, and the T‐maze test for working memory. Four groups of rats received either no stress, maternal deprivation, corticosterone treatment, or both. Dorsal hippocampus sections obtained from parallel groups were used for BDNF mRNA in situ hybridization. Rats which had undergone both maternal deprivation and corticosterone treatment displayed a unique and significant 25–35% reduction of BDNF expression in the dentate gyrus (DG), and similar trends in the CA1 and CA3 regions of the hippocampus. These “two‐hit” animals exhibited a learning delay in the Morris water maze test, a marked deficit in the Y‐maze, but little change in the T‐maze test. However, some aspects of cognition were also altered in rats with either maternal deprivation or corticosterone treatment. This study demonstrates a persistent effect of two developmental disruptions on BDNF expression in the hippocampus, with parallel, but not completely correlative changes in learning and memory.
- 8 April 2008
- Published by Wiley in Hippocampus
- Vol. 18 (7) , 655-667
Combined neonatal stress and young‐adult glucocorticoid stimulation in rats reduce BDNF expression in hippocampus: Effects on learning and memory
Epidemiological studies suggest that multiple developmental disruptions are involved in the etiology of psychiatric illnesses including schizophrenia. In addition, altered expression of brain‐derived neurotrophic factor (BDNF) has been implicated in these illnesses. In the present study, we examined the combined long‐term effect of an early stress, in the form of maternal deprivation, and a later stress, simulated by chronic young‐adult treatment with the stress hormone, corticosterone, on BDNF expression in the hippocampus of rats. To assess whether there were behavioral effects, which may correlate with the BDNF changes, learning and memory was tested in the Y‐maze test for short term spatial memory, the Morris water maze for long‐term spatial memory, and the T‐maze test for working memory. Four groups of rats received either no stress, maternal deprivation, corticosterone treatment, or both. Dorsal hippocampus sections obtained from parallel groups were used for BDNF mRNA in situ hybridization. Rats which had undergone both maternal deprivation and corticosterone treatment displayed a unique and significant 25–35% reduction of BDNF expression in the dentate gyrus (DG), and similar trends in the CA1 and CA3 regions of the hippocampus. These “two‐hit” animals exhibited a learning delay in the Morris water maze test, a marked deficit in the Y‐maze, but little change in the T‐maze test. However, some aspects of cognition were also altered in rats with either maternal deprivation or corticosterone treatment. This study demonstrates a persistent effect of two developmental disruptions on BDNF expression in the hippocampus, with parallel, but not completely correlative changes in learning and memory.
- 29 February 2008
- Published by Elsevier in Neuropharmacology
- Vol. 54 (2) , 399-404
Does angiotensin interact with dopaminergic mechanisms in the brain to modulate prepulse inhibition in mice?
- 29 February 2008
- Published by Elsevier in Neuropharmacology
- Vol. 54 (2) , 399-404
Does angiotensin interact with dopaminergic mechanisms in the brain to modulate prepulse inhibition in mice?
- 9 August 2007
- Published by Springer Nature in Psychopharmacology
- Vol. 195 (2) , 273-283
Mice deficient in the alpha subunit of Gz show changes in pre-pulse inhibition, anxiety and responses to 5-HT1A receptor stimulation, which are strongly dependent on the genetic background
Rationale Gz, a member of the Gi G protein family, is involved in the coupling of dopaminergic and serotonergic receptors. In the present study, we investigated behaviour of mice deficient in the α subunit of Gz and focused on pre-pulse inhibition (PPI) and anxiety-like responses and the role of serotonin-1A (5-HT1A) receptors. Materials and methods We compared male and female wild-type and knock-out mice on either a C57Bl/6 or Balb/c background. We used automated startle boxes to assess startle and PPI and elevated plus maze to assess anxiety-like behaviours. Results Balb/c mice showed higher baseline PPI than C57Bl/6 mice, and there was no difference between the genotypes. The 5-HT1A receptor agonist, 8-hydroxy-di-propylaminotetralin (8-OH-DPAT), had no effect on PPI in C57Bl/6 mice but markedly increased PPI in Balb/c mice, with the effect being attenuated in Gαz knock-outs. On the elevated plus maze, there was little effect of the knock-out or 8-OH-DPAT in C57Bl/6 mice, whereas in Balb/c mice, Gαz knock-outs showed a phenotype of high levels of anxiety-like behaviour. 8-OH-DPAT was anxiogenic in Balb/c mice, but this effect was attenuated in Gαz knock-outs. Conclusions 5-HT1A receptors couple to Gz. In a strictly background strain-dependent manner, Gαz knock-out mice display high levels of anxiety-like behaviour and are less sensitive to the action of 8-OH-DPAT. Balb/c mice show much more clear effects of the Gαz knock-out than C57Bl/6 mice, which are often considered the standard background strain for genetic modifications. Therefore, our results suggest caution when studying the behavioural effects of genetic modifications only in C57Bl/6 mice.
- 9 August 2007
- Published by Springer Nature in Psychopharmacology
- Vol. 195 (2) , 273-283
Mice deficient in the alpha subunit of Gz show changes in pre-pulse inhibition, anxiety and responses to 5-HT1A receptor stimulation, which are strongly dependent on the genetic background
Rationale Gz, a member of the Gi G protein family, is involved in the coupling of dopaminergic and serotonergic receptors. In the present study, we investigated behaviour of mice deficient in the α subunit of Gz and focused on pre-pulse inhibition (PPI) and anxiety-like responses and the role of serotonin-1A (5-HT1A) receptors. Materials and methods We compared male and female wild-type and knock-out mice on either a C57Bl/6 or Balb/c background. We used automated startle boxes to assess startle and PPI and elevated plus maze to assess anxiety-like behaviours. Results Balb/c mice showed higher baseline PPI than C57Bl/6 mice, and there was no difference between the genotypes. The 5-HT1A receptor agonist, 8-hydroxy-di-propylaminotetralin (8-OH-DPAT), had no effect on PPI in C57Bl/6 mice but markedly increased PPI in Balb/c mice, with the effect being attenuated in Gαz knock-outs. On the elevated plus maze, there was little effect of the knock-out or 8-OH-DPAT in C57Bl/6 mice, whereas in Balb/c mice, Gαz knock-outs showed a phenotype of high levels of anxiety-like behaviour. 8-OH-DPAT was anxiogenic in Balb/c mice, but this effect was attenuated in Gαz knock-outs. Conclusions 5-HT1A receptors couple to Gz. In a strictly background strain-dependent manner, Gαz knock-out mice display high levels of anxiety-like behaviour and are less sensitive to the action of 8-OH-DPAT. Balb/c mice show much more clear effects of the Gαz knock-out than C57Bl/6 mice, which are often considered the standard background strain for genetic modifications. Therefore, our results suggest caution when studying the behavioural effects of genetic modifications only in C57Bl/6 mice.
- 1 March 2007
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 320 (3) , 1224-1236
Differential Effects of Antipsychotic Drugs on Serotonin-1A Receptor-Mediated Disruption of Prepulse Inhibition
Serotonin-1A (5-HT1A) receptors have been implicated in the symptoms of schizophrenia. However, there is limited in vivo evidence for an interaction of antipsychotic drugs with 5-HT1A receptor-mediated behavioral effects. We therefore investigated in rats the action of several antipsychotic drugs on prepulse inhibition (PPI), a measure of sensorimotor gating that is deficient in schizophrenia. Disruption of PPI at the 100-ms interstimulus interval (ISI), but not the 30-ms ISI, was induced by treatment with 0.5 mg/kg 8-hydroxy-di-propylaminotetralin (8-OH-DPAT), the 5-HT1A receptor agonist. In rats pretreated with 0.25 mg/kg haloperidol (4-[-4-(p-chlorophenyl)-4-hydroxypiperidino]-4′-fluoro butyrophenone) or raclopride [3,5-dichloro-N-(1-ethylpyrrolidin-2-ylmethyl)-2-hydroxy-6-methoxybenzamide tartrate], the disruption of PPI was no longer significant. Of the atypical antipsychotic drugs clozapine (8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]-diazepine), olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine), risperidone [3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl) piperidino] ethyl-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one)], amisulpride (4-amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-o-anisamide), and aripiprazole (7-[4-[-4[-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyrilor 7-[4-[4-(2,3-dichlorophenyl) piperazin-1-yl]butoxy]-1,2,3,4,-tetrahydroquinolin-2-one), only aripiprazole significantly reduced the effect of 8-OH-DPAT on PPI. This effect was mimicked by pretreatment with the 5-HT1A receptor partial agonist, buspirone [N-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione hydrochloride]. On the other hand, some of the antipsychotic drugs and other pretreatments showed complex, prepulse-dependent effects on their own. These data show little in vivo interaction of several atypical antipsychotic drugs with the disruption of PPI mediated by 5-HT1A receptor stimulation. The action of haloperidol and raclopride suggests a major involvement of dopamine D2 receptors in this effect, possibly downstream from the initial serotonergic stimulation. The action of aripiprazole could be mediated by its partial agonist properties at 5-HT1A receptors or its dopamine D2-blocking properties.
- 1 March 2007
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 320 (3) , 1224-1236
Differential Effects of Antipsychotic Drugs on Serotonin-1A Receptor-Mediated Disruption of Prepulse Inhibition
Serotonin-1A (5-HT1A) receptors have been implicated in the symptoms of schizophrenia. However, there is limited in vivo evidence for an interaction of antipsychotic drugs with 5-HT1A receptor-mediated behavioral effects. We therefore investigated in rats the action of several antipsychotic drugs on prepulse inhibition (PPI), a measure of sensorimotor gating that is deficient in schizophrenia. Disruption of PPI at the 100-ms interstimulus interval (ISI), but not the 30-ms ISI, was induced by treatment with 0.5 mg/kg 8-hydroxy-di-propylaminotetralin (8-OH-DPAT), the 5-HT1A receptor agonist. In rats pretreated with 0.25 mg/kg haloperidol (4-[-4-(p-chlorophenyl)-4-hydroxypiperidino]-4′-fluoro butyrophenone) or raclopride [3,5-dichloro-N-(1-ethylpyrrolidin-2-ylmethyl)-2-hydroxy-6-methoxybenzamide tartrate], the disruption of PPI was no longer significant. Of the atypical antipsychotic drugs clozapine (8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]-diazepine), olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine), risperidone [3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl) piperidino] ethyl-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one)], amisulpride (4-amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-o-anisamide), and aripiprazole (7-[4-[-4[-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyrilor 7-[4-[4-(2,3-dichlorophenyl) piperazin-1-yl]butoxy]-1,2,3,4,-tetrahydroquinolin-2-one), only aripiprazole significantly reduced the effect of 8-OH-DPAT on PPI. This effect was mimicked by pretreatment with the 5-HT1A receptor partial agonist, buspirone [N-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione hydrochloride]. On the other hand, some of the antipsychotic drugs and other pretreatments showed complex, prepulse-dependent effects on their own. These data show little in vivo interaction of several atypical antipsychotic drugs with the disruption of PPI mediated by 5-HT1A receptor stimulation. The action of haloperidol and raclopride suggests a major involvement of dopamine D2 receptors in this effect, possibly downstream from the initial serotonergic stimulation. The action of aripiprazole could be mediated by its partial agonist properties at 5-HT1A receptors or its dopamine D2-blocking properties.
- 1 August 2006
- Published by Springer Nature in Psychopharmacology
- Vol. 188 (1) , 100-110
Oestrogen modulation of the effect of 8-OH-DPAT on prepulse inhibition: effects of aromatase deficiency and castration in mice
The aim of this study was to investigate the interaction of sex steroid hormones, particularly oestrogen, in the regulation of prepulse inhibition (PPI) by serotonin-1A (5-HT1A) receptors. We studied aromatase knockout (ArKO) mice, which are unable to produce oestrogen but have high levels of testosterone, and the effects of castration. Treatment of male ArKO mice with the 5-HT1A receptor agonist, 8-hydroxy-dipropyl-aminotetralin (8-OH-DPAT), caused an increase in PPI that was significantly greater than in male wild-type controls. Castration of male mice caused a significant enhancement of the effect of 8-OH-DPAT in control mice; however, there was no change in the effect of this drug in ArKO mice. There was no significant effect of 8-OH-DPAT on PPI in either female ArKO or wild-type controls. In all experiments, the effects of 8-OH-DPAT on startle were not different between the groups. [3H]8-OH-DPAT autoradiography showed no differences in 5-HT1A receptor binding densities in areas of the forebrain, hippocampus or raphe region that could explain the PPI results. These data show that the absence of oestrogen in male ArKO mice leads to a greater effect of 5-HT1A receptor stimulation on PPI. This effect can be mimicked in male control mice by castration. The differential involvement of oestrogen and testosterone in these animal models is discussed.
- 1 August 2006
- Published by Springer Nature in Psychopharmacology
- Vol. 188 (1) , 100-110
Oestrogen modulation of the effect of 8-OH-DPAT on prepulse inhibition: effects of aromatase deficiency and castration in mice
The aim of this study was to investigate the interaction of sex steroid hormones, particularly oestrogen, in the regulation of prepulse inhibition (PPI) by serotonin-1A (5-HT1A) receptors. We studied aromatase knockout (ArKO) mice, which are unable to produce oestrogen but have high levels of testosterone, and the effects of castration. Treatment of male ArKO mice with the 5-HT1A receptor agonist, 8-hydroxy-dipropyl-aminotetralin (8-OH-DPAT), caused an increase in PPI that was significantly greater than in male wild-type controls. Castration of male mice caused a significant enhancement of the effect of 8-OH-DPAT in control mice; however, there was no change in the effect of this drug in ArKO mice. There was no significant effect of 8-OH-DPAT on PPI in either female ArKO or wild-type controls. In all experiments, the effects of 8-OH-DPAT on startle were not different between the groups. [3H]8-OH-DPAT autoradiography showed no differences in 5-HT1A receptor binding densities in areas of the forebrain, hippocampus or raphe region that could explain the PPI results. These data show that the absence of oestrogen in male ArKO mice leads to a greater effect of 5-HT1A receptor stimulation on PPI. This effect can be mimicked in male control mice by castration. The differential involvement of oestrogen and testosterone in these animal models is discussed.
- 1 June 2006
- Published by Elsevier in Experimental Neurology
- Vol. 199 (2) , 438-445
Improved spatial recognition memory in mice lacking adenosine A2A receptors
- 1 June 2006
- Published by Elsevier in Experimental Neurology
- Vol. 199 (2) , 438-445
Improved spatial recognition memory in mice lacking adenosine A2A receptors
- 1 April 2006
- Published by Wiley in British Journal of Pharmacology
- Vol. 147 (7) , 800-807
Effects of haloperidol and clozapine on sensorimotor gating deficits induced by 5‐hydroxytryptamine depletion in the brain
Evidence is increasing for a role of brain 5‐hydroxytryptamine (5‐HT) systems in schizophrenia. We previously showed that brain 5‐HT depletion causes disruption of prepulse inhibition, a measure of sensorimotor gating that is deficient in schizophrenia. Antipsychotic treatment has been reported to reverse these deficits in patients with schizophrenia. The present study was designed to investigate the ability of antipsychotic drugs to reverse prepulse inhibition deficits caused by lesions of the brain 5‐HT system in rats. In male Sprague–Dawley rats, selected parts of the brain 5‐HT systems were lesioned by micro‐injection of the 5‐HT neurotoxin 5,7‐dihydroxytryptamine into the dorsal raphe nucleus (DRN) or median raphe nucleus (MRN). The effects of antipsychotic drugs on lesion‐induced changes in prepulse inhibition were examined 2 weeks after the surgery. There was significant disruption of prepulse inhibition in the MRN‐lesioned group compared to sham‐operated controls. This deficiency in prepulse inhibition was restored by clozapine (1 and 5 mg kg−1) treatment, and by treatment with a relatively high dose of haloperidol (0.25 mg kg−1). There was no significant effect of the DRN lesions on prepulse inhibition compared with sham‐operated controls. These results indicate that 5‐HT depletion in MRN‐innervated brain structures leads to disruption of prepulse inhibition. Treatment with both antipsychotic drugs, haloperidol and clozapine, significantly increased prepulse inhibition in these animals back to the level seen in sham‐operated controls. The present findings highlight the importance of the 5‐HT systems in cognitive models of schizophrenia. British Journal of Pharmacology (2006) 147, 800–807. doi:10.1038/sj.bjp.0706641
- 1 April 2006
- Published by Wiley in British Journal of Pharmacology
- Vol. 147 (7) , 800-807
Effects of haloperidol and clozapine on sensorimotor gating deficits induced by 5‐hydroxytryptamine depletion in the brain
Evidence is increasing for a role of brain 5‐hydroxytryptamine (5‐HT) systems in schizophrenia. We previously showed that brain 5‐HT depletion causes disruption of prepulse inhibition, a measure of sensorimotor gating that is deficient in schizophrenia. Antipsychotic treatment has been reported to reverse these deficits in patients with schizophrenia. The present study was designed to investigate the ability of antipsychotic drugs to reverse prepulse inhibition deficits caused by lesions of the brain 5‐HT system in rats. In male Sprague–Dawley rats, selected parts of the brain 5‐HT systems were lesioned by micro‐injection of the 5‐HT neurotoxin 5,7‐dihydroxytryptamine into the dorsal raphe nucleus (DRN) or median raphe nucleus (MRN). The effects of antipsychotic drugs on lesion‐induced changes in prepulse inhibition were examined 2 weeks after the surgery. There was significant disruption of prepulse inhibition in the MRN‐lesioned group compared to sham‐operated controls. This deficiency in prepulse inhibition was restored by clozapine (1 and 5 mg kg−1) treatment, and by treatment with a relatively high dose of haloperidol (0.25 mg kg−1). There was no significant effect of the DRN lesions on prepulse inhibition compared with sham‐operated controls. These results indicate that 5‐HT depletion in MRN‐innervated brain structures leads to disruption of prepulse inhibition. Treatment with both antipsychotic drugs, haloperidol and clozapine, significantly increased prepulse inhibition in these animals back to the level seen in sham‐operated controls. The present findings highlight the importance of the 5‐HT systems in cognitive models of schizophrenia. British Journal of Pharmacology (2006) 147, 800–807. doi:10.1038/sj.bjp.0706641
- 15 March 2006
- Published by Elsevier in Behavioural Brain Research
- Vol. 168 (1) , 74-82
Differential involvement of 5-HT projections within the amygdala in prepulse inhibition but not in psychotomimetic drug-induced hyperlocomotion
- 15 March 2006
- Published by Elsevier in Behavioural Brain Research
- Vol. 168 (1) , 74-82
Differential involvement of 5-HT projections within the amygdala in prepulse inhibition but not in psychotomimetic drug-induced hyperlocomotion
- 18 November 2005
- Published by Elsevier in Brain Research
- Vol. 1064 (1-2) , 10-20
The effect of low estrogen state on serotonin transporter function in mouse hippocampus: A behavioral and electrochemical study
- 18 November 2005
- Published by Elsevier in Brain Research
- Vol. 1064 (1-2) , 10-20
The effect of low estrogen state on serotonin transporter function in mouse hippocampus: A behavioral and electrochemical study